Blue Owl Capital (NYSE:OWL) Lifted to “Outperform” at Oppenheimer

Blue Owl Capital (NYSE:OWL) was upgraded by stock analysts at Oppenheimer from a “market perform” rating to an “outperform” rating in a note issued to investors on Friday, Briefing.com reports. The brokerage currently has a $21.00 price objective on the stock. Oppenheimer’s price objective suggests a potential upside of 22.24% from the company’s previous close.

OWL has been the subject of several other research reports. Piper Sandler decreased their price target on Blue Owl Capital from $23.00 to $21.00 and set an “overweight” rating for the company in a research note on Wednesday, July 10th. Evercore ISI raised their target price on shares of Blue Owl Capital from $18.00 to $22.00 and gave the company an “outperform” rating in a research note on Thursday, April 4th. JMP Securities restated a “market outperform” rating and set a $24.00 price target on shares of Blue Owl Capital in a report on Tuesday, April 9th. TD Cowen reiterated a “hold” rating and issued a $19.00 price objective (down from $21.50) on shares of Blue Owl Capital in a research note on Monday, July 8th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $21.00 target price on shares of Blue Owl Capital in a report on Monday, June 10th. Three research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $20.31.

Blue Owl Capital Stock Performance

NYSE:OWL opened at $17.18 on Friday. The company has a market capitalization of $24.55 billion, a P/E ratio of 143.17, a P/E/G ratio of 1.20 and a beta of 1.18. The stock’s 50 day moving average price is $18.10 and its 200 day moving average price is $17.88. Blue Owl Capital has a 52 week low of $10.64 and a 52 week high of $20.13.

Blue Owl Capital (NYSE:OWL) last announced its quarterly earnings results on Thursday, May 2nd. The company reported $0.17 EPS for the quarter, topping the consensus estimate of $0.16 by $0.01. The company had revenue of $486.55 million for the quarter, compared to analyst estimates of $478.47 million. Blue Owl Capital had a net margin of 3.84% and a return on equity of 18.15%. As a group, sell-side analysts forecast that Blue Owl Capital will post 0.81 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. Raymond James & Associates increased its holdings in shares of Blue Owl Capital by 28.6% in the fourth quarter. Raymond James & Associates now owns 394,162 shares of the company’s stock valued at $5,873,000 after purchasing an additional 87,768 shares in the last quarter. Raymond James Financial Services Advisors Inc. acquired a new stake in Blue Owl Capital in the fourth quarter worth about $204,000. Private Trust Co. NA raised its holdings in Blue Owl Capital by 112.8% during the 4th quarter. Private Trust Co. NA now owns 6,570 shares of the company’s stock worth $98,000 after purchasing an additional 3,483 shares during the last quarter. International Assets Investment Management LLC acquired a new position in Blue Owl Capital during the 4th quarter valued at about $1,690,000. Finally, Capital Insight Partners LLC boosted its stake in shares of Blue Owl Capital by 11.4% in the 4th quarter. Capital Insight Partners LLC now owns 22,368 shares of the company’s stock valued at $333,000 after purchasing an additional 2,282 shares during the last quarter. 35.85% of the stock is owned by institutional investors and hedge funds.

About Blue Owl Capital

Blue Owl Capital Inc operates as an asset manager in the United States. The company offers permanent capital base solutions that enables it to offer holistic framework of capital solutions to middle market companies, large alternative asset managers, and corporate real estate owners and tenants. It also provides direct lending products that offer private credit products comprising diversified, technology, first lien, and opportunistic lending to middle-market companies; liquid credit; GP strategic capital products, which offers capital solutions, including GP minority stakes, GP debt financing, and professional sports minority stakes; and real estate products that focuses on acquiring triple net lease real estate by investment grade or creditworthy tenants.